Yondelis Intravenous infusion 0.25mg, manufactured by Taiho Pharmaceutical, contains Trabectedin, an antitumor chemotherapy medication. It is used for the treatment of advanced soft-tissue sarcoma and ovarian cancer. This 0.25mg bottle has a YJ code of 4291431D1027.
Yondelis Intravenous infusion 0.25mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).